Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
South Africa Drops J&J Bedaquiline Scrutiny After Generic Market Opens Up
J&J Agrees To Withdraw 2027 Secondary Patent; 40% Price Cut Agreed With Buyer
Jul 11 2024
•
By
Dean Rudge
• Source: Shutterstock
More from Regulation
More from Policy & Regulation